Is there an Exposure-Response Relationship for Nivolumab in Real-World NSCLC Patients?
Bellesoeur A, Ollier E, Allard M, Hirsch L, Boudou-Rouquette P, Arrondeau J, Thomas-Schoemann A, Tiako M, Khoudour N, Chapron J, Giraud F, Wislez M, Damotte D, Lupo A, Vidal M, Alexandre J, Goldwasser F, Tod M, Blanchet B.
Bellesoeur A, et al. Among authors: arrondeau j.
Cancers (Basel). 2019 Nov 13;11(11):1784. doi: 10.3390/cancers11111784.
Cancers (Basel). 2019.
PMID: 31766292
Free PMC article.